gms | German Medical Science

54. Jahrestagung der Norddeutschen Orthopädenvereinigung e. V.

Norddeutsche Orthopädenvereinigung

16.06. bis 18.06.2005, Hamburg

Charges of conservative in-patient treatment of degenerate diseases of the spine in the German DRG-system

Meeting Abstract

Search Medline for

  • corresponding author I. Rhomberg - Universitätsklinikum Münster, Klinik und Poliklinik für Allgemeine Orthopädie, Münster
  • R. Rödl - Münster
  • U. Liljenqvist - Münster

Norddeutsche Orthopädenvereinigung. 54. Jahrestagung der Norddeutschen Orthopädenvereinigung e.V.. Hamburg, 16.-18.06.2005. Düsseldorf, Köln: German Medical Science; 2005. Doc05novEP42

The electronic version of this article is the complete one and can be found online at: http://www.egms.de/en/meetings/nov2005/05nov123.shtml

Published: June 13, 2005

© 2005 Rhomberg et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Introduction

Patients with degenerate diseases of the spine who are treated conservatively possess a high importance for orthopaedic clinics. Till the beginning of 2004 the billed charges depended on the in-patient days. Since then the German DRG-system has become mandatory for all clinics. 2005 the G-DRG-system was refined and improved. How do the charges differ through the change?

Material and method

All cases with a degenerative spine disease which are treated conservatively in the Klinik und Poliklinik für Allgemeine Orthopädie from the Universitätsklinikum Münster in the years 2003 and 2004 are examined. The fictive charges for the whole collective are calculated and compared separately for the different systems used in the years 2003, 2004 and 2005.

Results

In the period from 2003 to 2005 the average charge per case decreases by approximately 30 percent.

Discussion

Why was the average charge per case lowered manifestly? Will it be possible to treat the degenerative spine diseases economic justifiable in the future? How should the orthopaedic clinics react on the changes through the G-DRG-system?